Skip to main content

Advertisement

Table 4 Percentage of participants engaging in specific intravaginal practices and laboratory parameters (vaginal flora, bacterial vaginosis, plasma, genital HIV RNA, IL-6, and IL-8) by condition. Plasma and CVL HIV RNA limit of detection was 20 copies/milliliter

From: A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study

  Experimental (SOC+ plus group intervention) Enhanced standard of care (SOC+) SOC+ versus experimental
N(%) Median(IQR) N(%) Median(IQR)  
  Baseline (N = 58) 6-month (N = 47) 12-month (N = 54) Baseline (N = 70) 6-month (N = 53) 12-month (N = 64) 6-month p-value 12-month p-value
Products used for intravaginal practices in the prior month
 Water 90.9% 31.0% 40.7% 92.5% 45.8% 54.7% 0.159 0.140
 Soap 63.6% 4.8% 27.8% 74.6% 29.2% 46.9% 0.013 0.042
 Cloth, sponge or a rag 54.6% 2.4% 18.5% 52.2% 16.7% 37.5% 0.061 0.031
 Traditional medicines 27.3% 2.4% 22.2% 29.9% 6.3% 42.2% 0.395 0.029
 Herbs or flowers from outdoors 20.0% 2.4% 5.6% 16.4% 10.4% 14.1% 0.170 0.147
 Lemon 10.9% 2.4% 9.3% 9.0% 2.1% 20.3% 0.924 0.111
 Salt 7.3% 2.4% 5.6% 10.5% 2.1% 7.8% 0.924 0.629
 Vinegar 3.6% 2.4% 7.4% 1.5% 2.1% 18.8% 0.924 0.090
Laboratory parameters
 Abnormal vaginal flora 72.7% 61.0% 66.7% 82.1% 60.0% 50.9% 0.926 0.090
 Bacterial vaginosis 60.0% 22.0% 27.5% 68.7% 11.1% 20.3% 0.186 0.383
 Detectable plasma HIV RNA 18.2% 11.9% 11.1% 23.9% 18.8% 38.9% 0.379 0.086
 Detectable CVL HIV RNA 12.7% 5.0% 5.6% 14.9% 15.9% 20.0% 0.134 0.244
 IL-6 (n = 68; Exp = 35, SOC+ = 33) 306.3 (313.7) 326.0 (313.1) -- 282.6 (249.1) 330.1 (261.6) -- 0.762 --
 IL-8 (n = 68; Exp = 35, SOC+ = 33) 380.11 (1311.9) 328.0 (1423.5) -- 227.5 (2285.5) 254.2 (1385.5) -- 0.651 --
  1. SOC+ enhanced standard of care
  2. CVL cervicovaginal lavage
  3. Bold: p < 0.05